|
|
|
Corporate Profile: Idera Pharmaceuticals
| Summary: |
| Idera Pharmaceuticals is focused on the development of TLR agonists as drug candidates to treat infectious diseases, autoimmune and inflammatory diseases, cancer, and respiratory diseases, and for use as vaccine adjuvants. |
| Address (HQ): |
167 Sidney Street
Cambridge, MA 02139 |
| Phone #'s (HQ): |
| Main |
(617) 679-5500 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(617) 679-5592 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| IDRA |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
